Table 1 Clinical Characteristics of Patients
Pt. (No.)
|
Diagnosis
|
Age/ Gender
|
EF (%)
|
RAP (mm Hg)
|
PCWP (mm Hg)
|
LAD (mm)
|
AF Duration
|
Presurgical Medication
|
|
MVD + AF
|
|
|
|
|
|
|
|
| 1 |
MVD |
69/F |
72 |
9 |
18 |
90 |
>3 yr |
Digoxin, enalapril, NTG, furosemide |
| 2 |
MVD |
47/M |
54 |
6 |
23 |
56 |
>5 yr |
Digoxin, furosemide |
| 3 |
MVD |
63/F |
72 |
9 |
12 |
52 |
>5 yr |
Enalapril, ISDN, furosemide, spironolactone |
| 4 |
MVD |
55/F |
66 |
4 |
10 |
66 |
>5 yr |
Digoxin |
| 5 |
MVD |
68/M |
56 |
1 |
12 |
88 |
>5 yr |
Benazepril, furosemide |
| 6 |
MVD |
73/F |
62 |
9 |
14 |
62 |
>5 yr |
Digoxin, furosemide, spironolactone |
| 7 |
MVD |
72/F |
64 |
8 |
26 |
83 |
>5 yr |
Digoxin, furosemide |
| 8 |
MVD |
52/M |
46 |
2 |
8 |
62 |
3 yr |
Digoxin, enalapril, furosemide |
| 9 |
MVD |
47/F |
58 |
5 |
15 |
64 |
2 yr |
Digoxin, enalapril, furosemide |
| 10 |
MVD |
63/F |
55 |
9 |
12 |
52 |
>5 yr |
Digoxin, enalapril, furosemide, spironolactone |
| 11 |
MVD |
57/F |
56 |
2 |
15 |
50 |
>5 yr |
Digoxin, enalapril, spironolactone |
| 12 |
MVD |
51/M |
67 |
5 |
12 |
48 |
>4 yr |
Digoxin, enalapril, furosemide, spironolactone |
| 13 |
MVD |
60/F |
64 |
6 |
18 |
54 |
>2 yr |
Digoxin, ISDN, furosemide, spironolactone |
|
Mean ± SD
|
61 ± 8 |
6 ± 3 |
15 ± 5 |
64 ± 15  |
|
|
MVD + NSR
|
|
|
|
|
|
|
|
| 1 |
MVD |
56/F |
72 |
5 |
16 |
46 |
|
Digoxin, enalapril, furosemide |
| 2 |
MVD |
64/F |
67 |
1 |
24 |
48 |
|
Digoxin, NTG, furosemide |
| 3 |
MVD |
70/F |
64 |
1 |
8 |
47 |
|
Furosemide |
| 4 |
MVD |
76/F |
78 |
10 |
8 |
52 |
|
Digoxin, spironolactone |
| 5 |
MVD |
64/F |
76 |
2 |
9 |
51 |
|
Alacepril, furosemide, spironolactone |
|
Mean ± SD
|
71 ± 6 |
4 ± 4 |
13 ± 7* |
49 ± 3* |
|
|
| Control |
|
|
|
|
|
|
|
|
| 1 |
IHD |
66/M |
60 |
2 |
7 |
35 |
|
Bisoprolol, ISMN, nicorandil |
| 2 |
IHD |
77/F |
60 |
4 |
8 |
36 |
|
ISDN, nicorandil, nifedipine |
| 3 |
IHD |
72/M |
70 |
1 |
2 |
38 |
|
Nipradilol, ISDN, diltiazem |
| 4 |
IHD |
57/M |
72 |
4 |
7 |
28 |
|
Bisoprolol, ISDN, nicorandil, diltiazem |
| 5 |
IHD |
61/M |
50 |
7 |
8 |
39 |
|
ISDN, diltiazem, enalapril |
| 6 |
IHD |
57/M |
65 |
5 |
8 |
33 |
|
Metoprolol, ISDN, amlodipine |
| 7 |
IHD |
66/M |
67 |
3 |
5 |
37 |
|
Betaxolol, ISDN, nicorandil |
| 8 |
IHD |
70/M |
74 |
3 |
5 |
35 |
|
Bisoprolol, nicorandil, diltiazem, enalapril |
|
Mean ± SD
|
64 ± 9
|
4 ± 2
|
6 ± 2
|
35 ± 4
|
|
|
|
* p < 0.05 compared with control;
p < 0.01 compared with control;
p < 0.05 compared with MVD + NSR.
AF = atrial fibrillation; EF = left ventricular ejection fraction; IHD = ischemic heart disease; ISDN = isosorbide dinitrate; ISMN = isosorbide mononitrate; LAD = left atrial diameter; MVD = mitral valvular disease; NSR = normal sinus rhythm; NTG = nitroglycerin; PCWP = pulmonary capillary wedge pressure; RAP = right atrial pressure.
|